ASF1A Human

ASF1 Anti-Silencing Function 1 Homolog A Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to ASF1A Human

ASF1A (Anti-silencing Function 1A) is a histone H3/H4 chaperone critical for chromatin dynamics, including nucleosome assembly, disassembly, and histone exchange during DNA replication, repair, and transcriptional regulation . It belongs to the evolutionarily conserved ASF1 family and is essential for maintaining genomic stability and epigenetic regulation . ASF1A is distinct from its paralog ASF1B, with unique roles in replication-independent chromatin assembly and cellular differentiation .

Role in Chromatin Dynamics

ASF1A regulates chromatin states through two primary pathways:

  1. Replication-Coupled (RC) Assembly: Partners with CAF-1 to deposit canonical histones (H3.1–H4) during DNA replication .

  2. Replication-Independent (RI) Assembly: Collaborates with HIRA to incorporate histone variant H3.3 into chromatin, critical for transcriptional regulation .

Key Findings:

  • Bivalent Domain Resolution: ASF1A resolves bivalent chromatin (H3K4me3/H3K27me3) at lineage-specific genes during embryonic stem cell differentiation by mediating nucleosome disassembly .

  • Senescence-Associated Heterochromatin Foci (SAHF): Required for SAHF formation, facilitating cell cycle exit during senescence .

Mechanisms in DNA Repair and Replication

ASF1A synergizes with CAF-1 to assemble nucleosomes during nucleotide excision repair (NER) . Studies in human cell-free systems demonstrate:

  • CAF-1 Dependency: ASF1A alone cannot promote nucleosome assembly but enhances CAF-1 activity by 2–3 fold in repaired DNA regions .

  • Direct Interaction: Binds CAF-1 p60 via β-domain motifs, enabling histone transfer during repair .

Table 2: Functional Synergy Between ASF1A and CAF-1 in DNA Repair

ParameterASF1A + CAF-1 ActivityCAF-1 Alone
Nucleosome AssemblyEnhanced supercoiling on repaired DNALimited
MNase Digestion PatternRegular nucleosome spacingIrregular
Salt StabilityRetains interaction at 1 M NaClUnstable

Oncogenic Overexpression:

  • ASF1A is upregulated in 20+ cancer types (TCGA/GTEx data), including hepatocellular carcinoma (HCC) and prostate cancer .

  • Mechanism: Depletion induces p53-dependent senescence via DNA damage accumulation and p21^CIP1 upregulation .

Clinical Correlations:

  • Survival Metrics: High ASF1A expression correlates with poor HCC prognosis (HR = 1.7 for DFS, P < 0.0001) .

  • Therapeutic Target: ASF1A inhibition triggers senescence in wild-type p53 cancer cells, suggesting potential for combination therapies .

ASF1A–HIRA Complex (PDB: 2I32):

  • Binding Interface: The HIRA B domain forms an antiparallel β-hairpin that docks perpendicularly to ASF1A’s β-sandwich .

  • Specificity Determinants: N/C-terminal regions of ASF1A dictate preferential binding to HIRA over CAF-1 .

ASF1A–Histone Interaction (PDB: 1TEY):

  • The histone H3 C-terminal helix binds a conserved hydrophobic groove on ASF1A, essential for chaperone activity .

Research Tools and Recombinant ASF1A Applications

  • Recombinant ASF1A: Produced in E. coli (27 kDa, >90% purity) for in vitro nucleosome assembly assays .

  • Functional Assays: Used to study SAHF formation, senescence, and chromatin remodeling .

Product Specs

Introduction
ASF1A, a histone chaperone protein within the H3/H4 family, originates from the yeast gene responsible for anti-silencing function-1. It plays a crucial role in nucleosome assembly as a component of the histone donor complex. Interacting with histones H3 and H4, ASF1A collaborates with a chromatin assembly factor during DNA replication and repair processes. Eliminating ASF1A in yeast and Drosophila leads to heightened sensitivity to DNA-damaging agents and replication inhibitors, increased genomic instability and sister chromatid exchange, and activation of the DNA damage checkpoint.
Description
Recombinantly produced in E. coli, ASF1A Human Recombinant is a single, non-glycosylated polypeptide chain comprising 240 amino acids (specifically, amino acids 1-204). With a molecular weight of 27kDa, it features a 36 amino acid His Tag and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
A colorless solution that has been sterilized through filtration.
Formulation
The ASF1A protein solution is formulated with 20mM Tris-HCl at a pH of 8, 1mM DTT, and 10% glycerol.
Stability
For optimal storage, keep at 4°C if the entire vial will be used within 2-4 weeks. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Minimize repeated freeze-thaw cycles.
Purity
SDS-PAGE analysis indicates a purity exceeding 90.0%.
Synonyms
CGI-98, HSPC146, DKFZp547E2110, ASF1A, Histone chaperone ASF1A, Anti-silencing function protein 1 homolog A, hAsf1, hAsf1a, CCG1-interacting factor A, CIA, hCIA.
Source
Escherichia Coli.
Amino Acid Sequence
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSMAKV QVNNVVVLDN PSPFYNPFQF EITFECIEDL SEDLEWKIIY VGSAESEEYD QVLDSVLVGP VPAGRHMFVF QADAPNPGLI PDADAVGVTV VLITCTYRGQ EFIRVGYYVN NEYTETELRE NPPVKPDFSK LQRNILASNPRVTRFHINWE DNTEKLEDAE SSNPNLQSLL STDALPSASK GWSTSENSLN VMLESHMDCM.

Q&A

What is the molecular function of ASF1A in human cells?

ASF1A functions as a major histone chaperone that regulates the supply of histone H3-H4 and facilitates nucleosome assembly to maintain chromatin structure. It plays an essential role in DNA-dependent processes including replication, repair, and transcription . The protein operates by binding to the H3-H4 dimer and transferring these histones to downstream chaperones like CAF-1 (Chromatin Assembly Factor 1) for incorporation into nucleosomes . This histone transfer function is critical for maintaining genomic integrity during cellular processes that require nucleosome disassembly and reassembly .

Experimentally, ASF1A function can be studied using cell-free systems that support processes like nucleotide excision repair (NER) on damaged plasmids. Supercoiling assays can be employed to monitor nucleosome formation, where the accumulation of supercoils is proportional to the number of nucleosomes formed on circular DNA .

How does ASF1A interact with CAF-1 in nucleosome assembly pathways?

ASF1A interacts directly with the p60 subunit of CAF-1 to facilitate nucleosome assembly. This interaction has been demonstrated through multiple experimental approaches:

  • Pull-down assays using GST-ASF1 fusion proteins show that GST-ASF1A can efficiently pull down the CAF-1 subunits p150 and p60 from human cell-free extracts .

  • Reciprocal immunoprecipitation experiments confirm that ASF1A co-immunoprecipitates with native p60, with interactions stable even in 1M NaCl conditions .

  • Direct binding studies with purified components demonstrate that ASF1A interacts specifically with the p60 subunit of CAF-1, not with p150 or p48 .

The functional significance of this interaction is evidenced by synergistic activity in nucleosome assembly coupled to DNA repair. When ASF1A is added together with CAF-1 and purified histones to a cell-free system supporting nucleotide excision repair, there is a marked increase in nucleosome assembly specifically on repaired DNA compared to either protein alone .

What experimental methods are most effective for studying ASF1A-mediated nucleosome assembly?

Several complementary experimental approaches have proven effective for investigating ASF1A function:

MethodApplicationKey Measurements
Supercoiling AssayNucleosome assemblyFormation of supercoiled DNA molecules
MNase DigestionNucleosome spacingDetection of mono-, di-, tri-nucleosomal fragments
Pull-down AssaysProtein-protein interactionsIdentification of interacting partners
ImmunoprecipitationComplex formation in vivoCo-precipitation of binding partners
Bio-Layer Interferometry (BLI)Binding kineticsAssociation (kon) and dissociation (koff) rates
Cryo-EMStructural analysisComplex architectures at near-atomic resolution

For nucleosome assembly studies specifically, the supercoiling assay provides a quantitative measure where the accumulation of supercoils is proportional to the number of nucleosomes formed on circular DNA. Partial micrococcal nuclease (MNase) digestion of assembled DNA can confirm that the observed supercoiling is due to the deposition of regularly spaced nucleosomes .

How does CODANIN-1 negatively regulate ASF1A function at the molecular level?

CODANIN-1 acts as a negative regulator of ASF1A through a sophisticated molecular mechanism revealed by cryo-EM structural studies. The 3.75 Å resolution structure of the human CODANIN-1_ASF1A complex has shown that:

  • CODANIN-1 forms a dimer where each monomer can hold two ASF1A molecules .

  • The binding occurs through two distinct modules in CODANIN-1: a B-domain and a histone H3 mimic helix (HMH) .

  • The interaction effectively hijacks ASF1A by occupying its binding sites for both histones and downstream chaperones .

Specifically, CODANIN-1 has two ASF1A-binding modules:

  • A distal ASF1A-binding module (BD-N and HMH-N)

  • A proximal ASF1A-binding module (BD-C and HMH-C)

Binding kinetics analysis through Bio-Layer Interferometry (BLI) has revealed that wild-type CODANIN-1 has a 12.7 × 10^4 kon (M^-1 s^-1) for ASF1A binding, with no measurable dissociation (koff) . Among the individual binding domains, BD-N shows the strongest binding to ASF1A, resulting in a 10-fold reduction in kon when mutated .

Through this sequestration mechanism, CODANIN-1 inhibits the formation of the ASF1A/H3-H4 complex and retains ASF1A in the cytoplasm, preventing it from participating in nucleosome assembly .

What is the structural basis for the interaction between ASF1A and histone H3-H4?

ASF1A interacts with the histone H3-H4 dimer through specific structural elements. CODANIN-1's ability to inhibit this interaction provides valuable insights into the ASF1A-histone binding interface. The histone H3 mimic helix (HMH) of CODANIN-1 mimics the structure of histone H3's α3 helix, which is critical for ASF1A binding .

Key findings about this structural interaction include:

  • The HMH domains of CODANIN-1 (HMH-N and HMH-C) mimic the histone H3 binding surface to occupy the histone-binding pocket of ASF1A .

  • Mutational studies of the HMH domains reveal that specific residues are critical for this interaction:

    • Mutations L545A/L549A in HMH-C significantly reduce ASF1A binding .

    • The hydrophobic residues in the HMH are particularly important for mimicking histone H3 binding .

When mutations are introduced to both the BD-N (R195A/R196A) and HMH-C (L545A/L549A) domains simultaneously, ASF1A binding is completely abolished, confirming the critical nature of these interaction surfaces .

How do mutations in ASF1A binding domains affect its function in DNA repair?

Mutations in ASF1A's binding domains can significantly impact its function in DNA repair processes. The synergistic activity between ASF1A and CAF-1 in nucleosome assembly coupled to nucleotide excision repair (NER) depends on their specific interaction .

Experimental evidence shows:

  • ASF1A functions synergistically with CAF-1 to assemble nucleosomes during NER, but this activity requires an intact interaction interface .

  • B-domains contribute more critically to ASF1A binding than HMH domains, as demonstrated by BLI experiments where mutations of both BD-N and BD-C (Mut8) strongly abrogated binding to ASF1A .

The critical nature of these interactions is highlighted by the observation that disrupting the ASF1A-CAF-1 interaction can impair nucleosome assembly during DNA repair. In yeast, defects in Asf1p significantly increase the sensitivity of cac-1 mutants to UV irradiation, and asf1 mutants alone are hypersensitive to a range of DNA-damaging agents, suggesting that proper ASF1-CAF-1 interaction is essential for the DNA damage response .

What methodological approaches are optimal for characterizing ASF1A interactions with different binding partners?

Characterizing ASF1A's interactions with various binding partners requires a multi-faceted methodological approach:

TechniqueApplicationAdvantagesLimitations
GST PulldownInitial identification of binding partnersSimple, effective for strong interactionsMay miss transient interactions
Co-immunoprecipitationVerification of interactions in cellular contextConfirms physiologically relevant complexesAntibody quality can affect results
Bio-Layer InterferometryQuantitative binding kineticsProvides kon and koff ratesRequires purified proteins
Cryo-EMStructural characterization of complexesNear-atomic resolution of large complexesSample preparation challenges
Mutational AnalysisIdentification of critical binding residuesPinpoints functional domainsMutations may affect protein folding
Cell-free Assembly AssaysFunctional consequences of interactionsTests biological activityLimited to in vitro conditions

For studying ASF1A interactions specifically, bio-layer interferometry (BLI) has proven particularly valuable. This technique allowed researchers to determine that wild-type CODANIN-1 has a 12.7 × 10^4 kon (M^-1 s^-1) for ASF1A binding with no measurable dissociation, while various mutations in the binding domains showed different effects on binding kinetics .

Combining structural studies with functional assays provides the most comprehensive understanding of ASF1A interactions. For example, the supercoiling assay coupled with partial MNase digestion can confirm the functional relevance of interactions observed in binding studies .

How does phosphorylation affect ASF1A function in cellular processes?

Phosphorylation represents an important regulatory mechanism for ASF1A activity. Unlike yeast Asf1p, human ASF1A (and ASF1B) are phosphorylated in a replication-dependent manner by Tousled-like kinases (Tlks) .

Key findings regarding ASF1A phosphorylation include:

  • Human ASF1A is phosphorylated by Tousled-like kinases in a manner dependent on DNA replication .

  • The C-terminal acidic stretch present in yeast Asf1p is absent in human ASF1A; it has been suggested that phosphorylation of human ASF1A by Tlk might provide the structural equivalent to this acidic region .

  • Initial experiments suggest that phosphorylation status does not significantly affect the direct interaction between ASF1A and CAF-1 p60 in pulldown assays .

What are the unresolved questions regarding ASF1A functional differences from ASF1B?

A significant question in the field concerns the functional distinction between the two human ASF1 variants (ASF1A and ASF1B), which share 71% homology . While both variants can function synergistically with CAF-1 to assemble nucleosomes during nucleotide excision repair, there are hints of functional specialization:

  • A Triton-resistant ASF1A fraction has been detected by western blotting, representing the first hint of a distinction between the two proteins .

  • Both variants are phosphorylated in a replication-dependent manner by Tousled-like kinases, but the functional consequences of this phosphorylation may differ .

Future research should focus on determining:

  • The specific cellular contexts where ASF1A versus ASF1B may be preferentially utilized

  • Distinct binding partners unique to each variant

  • Differential regulation mechanisms that may exist for the two proteins

  • Potential specialization in different DNA-dependent processes (replication, repair, transcription)

How can advanced structural analysis further our understanding of ASF1A regulation?

  • High-resolution structures of ASF1A in complex with other regulatory partners beyond CODANIN-1

  • Conformational changes in ASF1A during the histone transfer process

  • Structural basis for potential ASF1A-ASF1B functional differences

  • Impact of post-translational modifications on ASF1A structure and interactions

Addressing these questions will require integrating multiple structural approaches:

  • Cryo-EM for large complexes

  • X-ray crystallography for high-resolution details of specific domains

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) for conformational dynamics

  • Integrative modeling approaches that combine multiple data types

Product Science Overview

Function and Mechanism

ASF1A is a key component of the histone donor complex, which interacts with histones H3 and H4 . It works in conjunction with chromatin assembly factors to facilitate the deposition, exchange, and removal of histones during nucleosome assembly and disassembly . This process is vital for maintaining chromatin structure and function during DNA replication and repair .

ASF1A also promotes homologous recombination-mediated repair of double-strand breaks (DSBs) at stalled or collapsed replication forks . It achieves this by mediating histone replacement at DSBs, leading to the recruitment of the MMS22L-TONSL complex and subsequent loading of RAD51 .

Biological Importance

The protein is involved in both replication-dependent and replication-independent chromatin assembly . It cooperates with chromatin assembly factor 1 (CAF-1) to promote replication-dependent chromatin assembly and with HIRA to promote replication-independent chromatin assembly . Additionally, ASF1A is involved in the nuclear import of the histone H3-H4 dimer together with importin-4 (IPO4) .

Clinical Relevance

Mutations or dysregulation of ASF1A have been associated with various diseases, including Spastic Paraplegia 7, Autosomal Recessive, and Fanconi Anemia, Complementation Group I . Understanding the function and regulation of ASF1A can provide insights into the mechanisms underlying these diseases and potentially lead to the development of targeted therapies.

Research and Applications

ASF1A is widely studied in the context of chromatin biology and epigenetics. Its role in histone chaperoning makes it a critical factor in understanding chromatin dynamics and gene regulation. Recombinant ASF1A proteins are used in various research applications to study these processes in detail .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.